Tyler Technologies Inc/ US9022521051 /
2024-05-24 9:59:55 PM | Chg. +0.78 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
491.69USD | +0.16% | 3,546 Turnover: 1.75 mill. |
-Bid Size: - | -Ask Size: - | 20.89 bill.USD | - | 124.57 |
GlobeNewswire
05-23
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire
05-23
Userfront Raises $5.3M Seed, Launches Transformational Auth and Identity Platform for SaaS Businesse...
GlobeNewswire
05-22
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
GlobeNewswire
05-21
Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power-Thru Combo Chip
GlobeNewswire
05-15
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire
05-13
Digital Journal sets sights on becoming Canada’s premier thought leadership platform with launch of ...
GlobeNewswire
05-09
FOX Factory Performance Vehicle Development Introduces the All-New Black Widow Limited Chevrolet Sil...
GlobeNewswire
05-08
CAULIPOWER, The Better-For-You Brand Reinventing America’s Favorite Comfort Foods, Announces Veteran...
GlobeNewswire
05-07
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
05-07
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
05-07
Hey Boo Boo! Three New Yogi Bear’s Jellystone Park Locations are Opening this Summer
GlobeNewswire
05-06
Cribl Joins Wiz Integration Program to Strengthen Security Posture with Data-Driven Insights
GlobeNewswire
05-06
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET I...
GlobeNewswire
05-02
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for Th...